Jan Voorberg Selected Research

Jan Voorberg Research Topics

Disease

23	Hemophilia A (Haemophilia) 01/2024 - 04/2002
19	Thrombotic Thrombocytopenic Purpura 12/2023 - 02/2005
11	Hemorrhage 11/2022 - 04/2002
10	acquired Thrombotic thrombocytopenic purpura 11/2020 - 09/2006
8	von Willebrand Diseases (von Willebrand's Disease) 11/2022 - 12/2006
5	Thrombosis (Thrombus) 02/2022 - 10/2011
4	Vascular System Injuries 11/2022 - 02/2002
3	Inflammation (Inflammations) 01/2022 - 05/2006
2	Wounds and Injuries (Trauma) 01/2021 - 01/2019
2	Disease Susceptibility (Diathesis) 10/2019 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2018
2	Atherosclerosis 01/2014 - 06/2006
1	Neoplasms (Cancer) 02/2024
1	Gray Platelet Syndrome 02/2023
1	Pulmonary Hypertension 01/2022
1	Immune System Diseases (Immune Disorders) 01/2021
1	Hermansky Pudlak syndrome 2 10/2019
1	Neutropenia 10/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2019
1	Hemorrhagic Disorders (Hemorrhagic Diathesis) 01/2019
1	Fever (Fevers) 10/2018
1	Chills 10/2018
1	Obesity 01/2018
1	Rheumatoid Arthritis 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018
1	Infections 01/2018
1	Microvillus inclusion disease 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2017
1	Retinal Detachment (Retinal Detachments) 07/2007
1	Paraproteinemias (Monoclonal Gammopathy) 07/2007
1	Monoclonal Gammopathy of Undetermined Significance 07/2007
1	Type 3 von Willebrand Disease 12/2006

Drug/Important Bio-Agent (IBA)

22	von Willebrand FactorIBA 02/2023 - 02/2002
21	AntibodiesIBA 01/2024 - 11/2002
16	AutoantibodiesIBA 10/2021 - 11/2011
15	Factor VIII (Coagulation Factor VIII)IBA 01/2023 - 04/2002
13	thiamine triphosphorate (TTP)IBA 12/2023 - 02/2005
13	Proteins (Proteins, Gene)FDA Link 11/2022 - 11/2003
7	EpitopesIBA 11/2020 - 02/2003
5	Metalloproteases (Metalloproteinases)IBA 01/2021 - 10/2011
5	ThrombospondinsIBA 01/2021 - 10/2011
5	DisintegrinsIBA 01/2021 - 10/2011
4	Peptides (Polypeptides)IBA 01/2018 - 02/2012
3	Hemostatics (Antihemorrhagics)IBA 06/2022 - 01/2019
3	Immunoglobulin G (IgG)IBA 01/2019 - 08/2008
2	Neutralizing AntibodiesIBA 01/2024 - 05/2021
2	Glycoproteins (Glycoprotein)IBA 11/2022 - 11/2016
2	EnzymesIBA 01/2021 - 07/2020
2	CoagulantsIBA 01/2019 - 01/2019
2	DisulfidesIBA 06/2012 - 12/2006
1	Fibrinogen (Factor I)FDA Link 02/2024
1	Polysaccharides (Glycans)IBA 12/2023
1	CollagenIBA 02/2022
1	PolymersIBA 10/2021
1	Programmed Cell Death 1 ReceptorIBA 05/2021
1	AntigensIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Adaptor Protein Complex 3IBA 10/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019
1	Anti-Idiotypic AntibodiesIBA 01/2019
1	Blood Coagulation Factors (Coagulation Factor)IBA 09/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	AutoantigensIBA 01/2018
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2018
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	Inosine Triphosphate (ITP)IBA 01/2018
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Cysteine (L-Cysteine)FDA Link 06/2012
1	IntegrasesIBA 04/2012
1	Alanine (L-Alanine)FDA Link 11/2011
1	Immunoglobulins (Immunoglobulin)IBA 11/2011
1	Recombinant ProteinsIBA 10/2011
1	Amino Acids FDA Link 10/2011
1	Monoclonal AntibodiesIBA 10/2011
1	ferric chlorideIBA 10/2011
1	Cystine (L-Cystine)IBA 12/2006
1	Thrombin FDA Link 06/2006
1	Angiopoietin-2IBA 05/2006
1	Endothelin-1 (Endothelin 1)IBA 05/2006
1	Chemokine CCL26IBA 05/2006
1	InterleukinsIBA 05/2006
1	P-SelectinIBA 05/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2002
1	von Willebrand factor drug combination factor VIIIIBA 04/2002
1	Blood Proteins (Serum Proteins)IBA 02/2002

Therapy/Procedure

5	Therapeutics 01/2019 - 05/2009
1	Endarterectomy (Thromboendarterectomy) 01/2022
1	Resuscitation 01/2021
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2018
1	Transjugular Intrahepatic Portasystemic Shunt 01/2018
1	Aftercare (After-Treatment) 02/2003